FDA O O O O
Adverse O O O O
Event O O O O
Reporting O O O O
System O O O O
(FAERS) O O O O
Electronic O O O O
Submissions O O O O
Updates O O O O
for O O O O
Electronic O O O O
Submission O O O O
of O O O O
Individual O O O O
Case O O O O
Safety O O O O
Reports O O O O
(ICSRs) O O O O
to O O O O
FAERS O O O O
FDA O O O O
recently O O O O
updated O O O O
the O O O O
following O O O O
guidances O O O O
for O O O O
industry O O O O
to O O O O
incorporate O O O O
technical O O O O
updates: O O O O
[E2B O O O O
(R3) O O O O
Electronic O O O O
Transmission O O O O
of O O O O
Individual O O O O
Case O O O O
Safety O O O O
Reports O O O O
Implementation O O O O
Guide O O O O
- O O O O
Data O O O O
Elements O O O O
and O O O O
Message O O O O
Specification](/regulatory-information/search-fda-guidance-documents/e2br3-electronic-transmission-individual-case-safety-reports-implementation-guide-data-elements-and) O O O O
and O O O O
[Appendix O O O O
to O O O O
the O O O O
Implementation O O O O
Guide O O O O
â€” O O O O
Backwards O O O O
and O O O O
Forwards O O O O
Compatibility](/regulatory-information/search-fda-guidance-documents/e2br3-electronic-transmission-individual-case-safety-reports-implementation-guide-appendix). O O O O
Premarketing Reason 3 O O
Safety Reason 3 O O
Reporting Reason 3 O O
In Reason 3 O O
preparation Reason 3 O O
for Reason 3 O O
the Reason 3 O O
electronic Reason 3 O O
transmission Reason 3 O O
of Reason 3 O O
premarketing Reason 3 O O
safety Reason 3 O O
reports Reason 3 O O
in Reason 3 O O
the Reason 3 O O
International Reason 3 O O
Council Reason 3 O O
for Reason 3 O O
Harmonisation Reason 3 O O
(ICH) Reason 3 O O
E2B(R3) Reason 3 O O
format, Reason 3 O O
FDA Reason 3 O O
has Reason 3 O O
posted Reason 3 O O
the Reason 3 O O
following Reason 3 O O
documents Reason 3 O O
regarding Reason 3 O O
the Reason 3 O O
electronic Reason 3 O O
submission Reason 3 O O
of Reason 3 O O
ICSRs Reason 3 O O
for Reason 3 O O
certain Reason 3 O O
investigational Reason 3 O O
new Reason 3 O O
drug Reason 3 O O
application Reason 3 O O
(IND) Reason 3 O O
safety Reason 3 O O
reports Reason 3 O O
for Reason 3 O O
drug Reason 3 O O
and Reason 3 O O
biological Reason 3 O O
products Reason 3 O O
and Reason 3 O O
IND-exempt Reason 3 O O
bioavailability/bioequivalence Reason 3 O O
(BA/BE) Reason 3 O O
safety Reason 3 O O
reports Reason 3 O O
to Reason 3 O O
FAERS. Reason 3 O O
These Reason 3 O O
documents Reason 3 O O
are Reason 3 O O
posted Reason 3 O O
to Reason 3 O O
help Reason 3 O O
sponsors Reason 3 O O
prepare Reason 3 O O
their Reason 3 O O
systems Reason 3 O O
for Reason 3 O O
electronic Reason 3 O O
submission Reason 3 O O
of Reason 3 O O
IND Reason 3 O O
safety Reason 3 O O
reports Reason 3 O O
in Reason 3 O O
the Reason 3 O O
E2B(R3) Reason 3 O O
format. Reason 3 O O
[Providing O O O O
Regulatory O O O O
Submissions O O O O
in O O O O
Electronic O O O O
Format: O O O O
IND O O O O
Safety O O O O
Reports O O O O
- O O O O
Draft O O O O
Guidance O O O O
for O O O O
Industry](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/providing-regulatory-submissions-electronic-format-ind-safety-reports-guidance-industry)(October O O O O
2019) O O O O
[Electronic O O O O
Submission O O O O
of O O O O
IND O O O O
Safety O O O O
Reports O O O O
- O O O O
Technical O O O O
Conformance O O O O
Guide](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/electronic-submission-ind-safety-reports-technical-conformance-guide)(April O O O O
2022) O O O O
[Technical O O O O
Specifications O O O O
Document O O O O
- O O O O
FDA O O O O
Regional O O O O
Implementation O O O O
Guide O O O O
for O O O O
E2B(R3) O O O O
Electronic O O O O
Transmission O O O O
of O O O O
Individual O O O O
Case O O O O
Safety O O O O
Reports O O O O
for O O O O
Drug O O O O
and O O O O
Biological O O O O
Products](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-regional-implementation-guide-e2br3-electronic-transmission-individual-case-safety-reports-drug)(August O O O O
2022) O O O O
[Electronic O O O O
Submission O O O O
of O O O O
Expedited O O O O
Safety O O O O
Reports O O O O
From O O O O
IND-Exempt O O O O
Studies O O O O
- O O O O
Draft O O O O
Guidance O O O O
for O O O O
Industry](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/electronic-submission-expedited-safety-reports-ind-exempt-babe-studies-guidance-industry)(August O O O O
2022) O O O O
[FDA O O O O
E2B(R3) O O O O
Core O O O O
and O O O O
Regional O O O O
Data O O O O
Elements O O O O
and O O O O
Business O O O O
Rules](/media/157982/download?attachment)(Excel O O O O
file O O O O
June O O O O
2023) O O O O
[FDA O O O O
ICSR O O O O
XML O O O O
Instances](/media/157983/download?attachment)(zip O O O O
file O O O O
January O O O O
2023) O O O O
Please O O O O
note, O O O O
FDA O O O O
is O O O O
not O O O O
currently O O O O
accepting O O O O
the O O O O
submission O O O O
of O O O O
premarket O O O O
ICSRs O O O O
in O O O O
the O O O O
E2B(R3) O O O O
format. O O O O
Please O O O O
continue O O O O
to O O O O
submit O O O O
IND O O O O
safety O O O O
reports O O O O
using O O O O
eCTD O O O O
format O O O O
and O O O O
IND-exempt O O O O
BA/BE O O O O
safety O O O O
reports O O O O
on O O O O
Form O O O O
FDA O O O O
3500A. O O O O
FDA O O O O
will O O O O
update O O O O
this O O O O
web O O O O
page O O O O
when O O O O
final O O O O
guidance O O O O
for O O O O
IND O O O O
safety O O O O
reporting O O O O
is O O O O
published, O O O O
and O O O O
when O O O O
FDA O O O O
will O O O O
accept O O O O
IND O O O O
and O O O O
IND-exempt O O O O
BA/BE O O O O
safety O O O O
reports O O O O
in O O O O
E2B(R3) O O O O
format O O O O
on O O O O
a O O O O
voluntary O O O O
basis. O O O O
Postmarketing Reason 3 O O
Safety Reason 3 O O
Reporting Reason 3 O O
In Reason 3 O O
preparation Reason 3 O O
for Reason 3 O O
the Reason 3 O O
receipt Reason 3 O O
of Reason 3 O O
postmarketing Reason 3 O O
safety Reason 3 O O
reports Reason 3 O O
in Reason 3 O O
the Reason 3 O O
E2B(R3) Reason 3 O O
format, Reason 3 O O
FDA Reason 3 O O
has Reason 3 O O
posted Reason 3 O O
the Reason 3 O O
following Reason 3 O O
documents Reason 3 O O
regarding Reason 3 O O
the Reason 3 O O
electronic Reason 3 O O
submission Reason 3 O O
of Reason 3 O O
safety Reason 3 O O
reports Reason 3 O O
for Reason 3 O O
drug Reason 3 O O
and Reason 3 O O
biological Reason 3 O O
products Reason 3 O O
to Reason 3 O O
FAERS. Reason 3 O O
These Reason 3 O O
documents Reason 3 O O
are Reason 3 O O
posted Reason 3 O O
to Reason 3 O O
help Reason 3 O O
prepare Reason 3 O O
systems Reason 3 O O
for Reason 3 O O
electronic Reason 3 O O
submissions Reason 3 O O
of Reason 3 O O
postmarketing Reason 3 O O
safety Reason 3 O O
reports. Reason 3 O O
[Technical O O O O
Specifications O O O O
Document O O O O
- O O O O
FDA O O O O
Regional O O O O
Implementation O O O O
Guide O O O O
for O O O O
E2B(R3) O O O O
Electronic O O O O
Transmission O O O O
of O O O O
Individual O O O O
Case O O O O
Safety O O O O
Reports O O O O
for O O O O
Drug O O O O
and O O O O
Biological O O O O
Products](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-regional-implementation-guide-e2br3-electronic-transmission-individual-case-safety-reports-drug)(August O O O O
2022) O O O O
[FDA O O O O
E2B(R3) O O O O
Core O O O O
and O O O O
Regional O O O O
Data O O O O
Elements O O O O
and O O O O
Business O O O O
Rules](/media/157982/download?attachment)(Excel O O O O
file O O O O
June O O O O
2023) O O O O
[FDA O O O O
E2B(R3) O O O O
Forward O O O O
Compatible O O O O
Rules](https://www.fda.gov/media/157993/download)(Excel O O O O
file O O O O
Instances](/media/157983/download?attachment)(zip O O O O
file O O O O
January O O O O
[Providing O O O O
Submissions O O O O
Format O O O O
- O O O O
Postmarketing O O O O
Safety O O O O
Reports: O O O O
Guidance O O O O
for O O O O
Industry](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/providing-submissions-electronic-format-postmarketing-safety-reports)(April O O O O
2022) O O O O
Please O O O O
note, O O O O
FDA O O O O
is O O O O
not O O O O
currently O O O O
accepting O O O O
the O O O O
submission O O O O
of O O O O
postmarketing O O O O
ICSRs O O O O
in O O O O
the O O O O
E2B(R3) O O O O
format. O O O O
FDA O O O O
will O O O O
update O O O O
this O O O O
web O O O O
page O O O O
when O O O O
postmarketing O O O O
ICSRs O O O O
will O O O O
be O O O O
accepted O O O O
in O O O O
the O O O O
E2B(R3) O O O O
format. O O O O
In O O O O
the O O O O
meantime, O O O O
please O O O O
continue O O O O
to O O O O
submit O O O O
postmarketing O O O O
ICSRs O O O O
in O O O O
the O O O O
E2B(R2) O O O O
format O O O O
